Gitte Pedersen

 Profile Provided By: https://www.linkedin.com/in/proximity/

Overview

Gitte Pedersen is the CEO & co founder of Genomic Expression Inc a company pioneering the development of sequence based cancer diagnostics.Prior to Genomic Expression she founded Proximity Venture Advisors an international business consulting company that serves high tech companies within the Life Science sector. She worked with biotech companies securing licensing deals reference clients and capital. Her deal resume is north of $1 billion.Proximity Venture Advisors clients were among the largest biotech and pharma corporations to some medium sized and smaller start up companies governmental organizations and universities. Since its inception Proximity Venture Advisors has worked with companies such as GlaxoSmithKline Amgen Genentech Johnson & Johnson Merck Wyeth Novo Nordisk Danida Takeda Aeras TB & Vaccine Foundation Procter & Gamble Qiagen SR One and Phoenix IP Venture Hadassah University Hospital.She have been involved in 5 start up situation co founder of 3 and done everything from business plan development to identification investors negotiation of deal terms.Previously Gitte worked for Novo Nordisk in a number of management positions within R&D and Marketing. Novo Nordisk is one of the largest Biotech Companies in the world and the market leader within areas such as industrial enzymes and insulin for treatment of diabetes. Gitte Pedersen co authored 8 patents while working in R&D.Gitte graduated from the Danish Technological University with top scores in Biochemical Engineering and she holds a bachelor in International Trade. She speaks English Danish and German fluently.